FA
IART icon

Friess Associates’s Integra LifeSciences IART Stock Holding History

Friess Associates’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-565,102
Closed -$19M – 152
2016
Q1 		$19M Buy
565,102
+72
+0% +$2.24K 1.9% 9
2015
Q4 		$19.1M Buy
565,030
+5,030
+0.9% +$157K 1.78% 11
2015
Q3 		$16.7M Buy
+560,000
New +$17.5M 1.55% 22

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Friess Associates's IART Position: Q2 2016 in Review

Friess Associates sold out of Integra LifeSciences (IART) in Q2 2016, closing a stake of 565,102 shares — an estimated $19M sold.

Friess Associates first reported a position in IART in Q3 2015 and held it in 3 quarters. The position peaked at $19.1M in Q4 2015. 210 funds tracked by Wall St. Rank hold IART as of Q2 2016.

  • Friess Associates reported no remaining Integra LifeSciences position as of Q2 2016 after selling out during the quarter.
  • Friess Associates sold 565,102 Integra LifeSciences shares in Q2 2016, an estimated $19M.
  • Friess Associates first reported a position in Integra LifeSciences in Q3 2015 and held it in 3 quarters.
  • Friess Associates's Integra LifeSciences position peaked at $19.1M in Q4 2015.
  • 210 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2016.

Based on Friess Associates's 13F filing for Q2 2016, filed 12 Aug 2016.